150,294 members

Skip to content. | Skip to navigation

News

Updated guidance to help GPs easily diagnose serious bowel conditions

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

Updated guidance to help GPs easily diagnose serious bowel conditions

The difficulty in distinguishing between Inflammatory Bowel Diseases (IBD) and Irritable Bowel Syndrome (IBS) can have a significant impact on individual wellbeing and health outcomes.

This consensus document supports frontline healthcare professionals by providing clarity about how faecal calprotectin testing should be delivered to simply and accurately distinguish between patients with IBD and IBS. By removing diagnostic uncertainty for individuals and the potential for unnecessary and invasive testing this should also reduce the pressure on endoscopy services nationally. By providing clarity on the appropriate testing regime, this document should drive the uptake of new care pathways leading to improved outcomes and improved patient experience. (An updated version of this document is now available.)